참고문헌
- Adeghate, E., Schattner, P., Dunn, E., 2006, An Update on the etiology and epidemiology of diabetes mellitus., Ann. N. Y. Acad. Sci., 1084, 1-29. https://doi.org/10.1196/annals.1372.029
- Ahmed, I., Adeghate, E., Sharma, A. K., Pallot, D. J., Singh, J., 1998, Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat., Diabetes. Res. Clin. Pract., 40, 145-151. https://doi.org/10.1016/S0168-8227(98)00022-9
- Beloin, N., Gbeassor, M., Akpagana, K., Hudson, J., de Soussa, K., Koumaglo, K., Arnason, J. T.. 2005, Ethnomedicinal uses of Momordica charantia (Cucurbitaceae) in Togo and relation to its phytochemistry and biological activity., J. Ethnopharmacol., 96, 49-55. https://doi.org/10.1016/j.jep.2004.08.009
- Bhat, G. A., Khan, H. A., Alhomida, A. S., Sharma, P., Singh, R., Paray, B. A., 2018, GLP-1 secretion in healthy and diabetic Wistar rats in response to aqueous extract of Momordica charantia., BMC Complement. Altern. Med., 18, 162. https://doi.org/10.1186/s12906-018-2227-4
- Consoli, A., 1992, Role of Liver in Pathophysiology of NIDDM., Diabetes. Care., 15, 430-441. https://doi.org/10.2337/diacare.15.3.430
- Elekofehinti, O. O., Ariyo, E. O., Akinijiyan, M. O., Olayeriju, O. S., Lawal, A. O., Adanlawo, I. G., Rocha, J. B. T., 2018, Potential use of bitter melon(Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies. Pathophysiology., 25, 327-333. https://doi.org/10.1016/j.pathophys.2018.05.003
- Grover, J. K., Rathi, S. S., Vats V., 2002, Amelioration of experimental diabetic neuropathy and gastropathy in rats following oral administration of plant(Eugenia jambolana, Mucuna pruriens and Tinospora cordifolia) extracts. Indian. J. Exp. Biol., 40, 273-276.
- Grover, J. K., Vats, V., Rathi, S. S., Dawar, R., 2001, Traditional Indian anti-diabetic plants attenuate progression of renal damage in streptozotocin induced diabetic mice. J. Ethnopharmacol., 76, 233-238. https://doi.org/10.1016/S0378-8741(01)00246-X
- Grover, J. K., Yadav, S. P., 2004, Pharmacological actions and potential uses of Momordica charantia: a review., J. Ethnopharmacol., 93, 123-132. https://doi.org/10.1016/j.jep.2004.03.035
- Jiang, G., Zhang, B. B., 2003, Glucagon and regulation of glucose metabolism., Am. J. Physiol. Endocrinol. Metab., 284, E671-E678. https://doi.org/10.1152/ajpendo.00492.2002
- Kim, J. W., Lee, Y. S., Seol, D. J., Cho, I. J., Ku, S. K., Choi, J. S., Lee, H. J.. 2018, Anti-obesity and fatty liver -preventing activities of Lonicera caerulea in high-fat diet-fed mice. Int. J. Mol. Med., 42, 3047-64.
- Kim, Y. J., Kim, H. K., Lee, H. S., 2018, Hypoglycemic effect of standardized Chrysanthemum zawadskii ethanol extract in high-fat diet/streptozotocin-induced diabetic mice and rats., Food. Sci. Biotechnol., 27, 1771-1779. https://doi.org/10.1007/s10068-018-0399-9
- Kyoung, S. P., 2018, DIABETES FACT SHEET IN KOREA. Korea Diabetes Association, Seoul, Korea.
- Lee, M. Y., Kim, M. K., Park, J. S., Lee, S. B., You, J. H., Ahn, C. W., Kim, K. R., Kang, S. N., 2019, Higher Glucagon-to-Insulin Ration Is Associated With Elevated Glycated Hemoglobin Levels in Type 2 Diabetes Patients., Korean. J. Intern. Med., 34, 1068-1077. https://doi.org/10.3904/kjim.2016.233
- Raman, A., Lau, C., 1996, Anti-diabetic properties phytochemistry of Momordica charantia L. (Cucurbitaceae)., Phytomedicine., 2, 349-362. https://doi.org/10.1016/S0944-7113(96)80080-8
- Rathi, S. S., Grover, J. K., Vikrant, V., Biswas, N. R.. 2002, Prevention of experimental diabetic cataract by Indian Ayurvedic plants extracts., Phytother. Res., 16, 774-777. https://doi.org/10.1002/ptr.1064
- Shih, C. C., Shlau, M. T., Lin, C. H., Wu, J. B., 2014, Momordica charantia Ameliorates Insulin Resistance and Dyslipidemia with Altered Hepatic Glucose Prodcution and Fatty Acid Synthesis and AMPK Phosphorylation in High-fat-fed Mice., Phytother. Res., 28, 363-371. https://doi.org/10.1002/ptr.5003
- Son, H. S., 2008, Early Diagnosis of Diabetes Mellitus. J. Korean. Med. Assoc., 51, 813-817. https://doi.org/10.5124/jkma.2008.51.9.813
- Stratton, I. M., Adler, A. I., Neil, H. A. W., Matthews, D. R., Manley, S. E., Cull, C. A., Hadden, D., Turner, R. C., Holman, R. R., 2000, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ., 321, 405-412. https://doi.org/10.1136/bmj.321.7258.405
- Vikrant, V., Grover, J. K., Tandon, N., Rathi, S. S., Gupta, N., 2001, Treatment with extracts of Momordica charantia and Eugenia jambolana prevents hyperglycemia and hyperinsulinemia in fructose fed rats. J. Ethnopharmacol., 76, 139-143. https://doi.org/10.1016/S0378-8741(01)00218-5
-
Wang, L., Waltenberger, B., Pferschy-Wenzig, E. M., Blunder, M., Liu, X., Malanier, C., Blazevic, T., Schwaiger, S., Rollinger, J. M., Heiss, E. H., Schuster, D., Kopp, B., Bauer, R., Stuppner, H., Dirsch, V. M., Atanasov, A. G., 2014, Natural product agonists of peroxisome proliferator-activated receptor gamma (
$PPAR{\gamma}$ ): a review. Biochem. Pharmacol., 92, 73-89. https://doi.org/10.1016/j.bcp.2014.07.018